Review Article| Volume 70, ISSUE 1, P83-90, February 2023

Inclusion of Children in Clinical Research

The Role of Advocacy and a Personal Journey


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Pediatric Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Moon M.R.
        • Khin-Maung-Gyi F.
        The history and role of institutional review boards.
        Virtual Mentor. 2009; 11: 311-321
      1. The belmont report: ethical principles and guidelines for the protection of human subjects of research.
        (Accessed July 7, 2022)
      2. (ORWH) history of women’s participation in clinical rearch.
        (Accessed July 7, 2022)
      3. FDA. Gender Studies in product development: historical overview.
        (Accessed July 7, 2022)
        • Kim E.S.
        • Menon V.
        Status of women in cardiovascular clinical trials.
        Arterioscler Thromb Vasc Biol. 2009; 29: 279-283
        • Merkatz R.B.
        Inclusion of women in clinical trials: a historical overview of scientific, ethical, and legal issues.
        J Obstet Gynecol Neonatal Nurs. 1998; 27: 78-84
        • National Institutes of Health
        NIH guidelines on the inclusion of women and minorities as subjects in clinical research.
        (Accessed July 7, 2022)
        • Denne S.C.
        • Hay Jr., W.W.
        Advocacy for research that benefits children: an obligation of pediatricians and pediatric investigators.
        JAMA Pediatr. 2013; 167: 792-794
      4. NICHD History.
        (Accessed July 7, 2022)
        • Children’s Oncology Group
        (Accessed July 7, 2022)
      5. NIH policy and guidelines on the inclusion of children as participants in research involving human subjects.
        (Accessed July 7, 2022)
        • Shirkey H.
        Therapeutic orphans.
        J Pediatr. 1968; 72: 119-120
      6. FDA modernization act of 1997.
        (Accessed July 7, 2022)
      7. Best pharmaceuticals for children act.
        (Accessed July 7, 2022)
      8. Pediatric research equity act of 2003.
        (Accessed July 7, 2022)
      9. FDA 2022 pediatric labeling changes.
        (Accessed July 7, 2022)
      10. 21st century cures Act.
        (Accessed July 7, 2022)
        • Bernard M.A.
        • Clayton J.A.
        • Lauer M.S.
        Inclusion across the lifespan: NIH policy for clinical research.
        JAMA. 2018; 320: 1535-1536
        • Lauer M.
        FY 2021 data on age at enrollment in clinical research.
        (Accessed July 7, 2022)
        • Caldwell C.S.
        • Denne S.C.
        Rigorous and consistent evaluation of diagnostic tests in children: another unmet need.
        Pediatr Res. 2020; 88: 524-525
        • Denne S.C.
        Including pregnant women in clinical research: time to overcome the barriers.
        Pediatr Res. 2019; 86: 554-555
        • Bibbins-Domingo K.
        • Helman A.
        • Dzau V.J.
        The imperative for diversity and inclusion in clinical trials and health research participation.
        JAMA. 2022;
        • Chen Jr., M.S.
        • Lara P.N.
        • Dang J.H.
        • et al.
        Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
        Cancer. 2014; 120: 1091-1096